Previous 10 | Next 10 |
Motley Fool news releases related Motley Fool news releases and Motley Fool press releases from 09/23/20 04:38:00 on US and Canada Markets.
The stock market can't seem to decide which way to go, and that's made September a bumpy month for the Nasdaq Composite (NASDAQINDEX: ^IXIC) . After it posted a significant gain Tuesday, investors were less confident in the benchmark's prospects on Wednesday. By around 3:30 p.m. EDT...
The stock market can't seem to decide which way to go, and that's made September a bumpy month for the Nasdaq Composite (NASDAQINDEX: ^IXIC) . After it posted a significant gain Tuesday, investors were less confident in the benchmark's prospects on Wednesday. By around 3:30 p.m. EDT...
Image source: The Motley Fool. General Mills Inc (NYSE: GIS) Q1 2021 Earnings Call Sep 23, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: General Mills Inc (GIS) Q1 2021 Earnings Call Transcript
Shares of embattled electric-truck start-up Nikola (NASDAQ: NKLA) closed down more than 25% on Wednesday, following reports that energy giant BP (NYSE: BP) has backed away from a potential partnership following allegations that Nikola has misled investors. Nikola's s...
Johnson & Johnson (NYSE: JNJ) has moved into phase 3 development of its coronavirus vaccine candidate, which goes by the code name JNJ-78436735. The study, called Ensemble, will enroll up to 60,000 volunteers across three continents. The company trails Moderna (NASDAQ:...
Johnson & Johnson (NYSE: JNJ) has moved into phase 3 development of its coronavirus vaccine candidate, which goes by the code name JNJ-78436735. The study, called Ensemble, will enroll up to 60,000 volunteers across three continents. The company trails Moderna (NASDAQ:...
Johnson & Johnson (NYSE: JNJ) has moved into phase 3 development of its coronavirus vaccine candidate, which goes by the code name JNJ-78436735. The study, called Ensemble, will enroll up to 60,000 volunteers across three continents. The company trails Moderna (NASDAQ:...
Johnson & Johnson (NYSE: JNJ) has moved into phase 3 development of its coronavirus vaccine candidate, which goes by the code name JNJ-78436735. The study, called Ensemble, will enroll up to 60,000 volunteers across three continents. The company trails Moderna (NASDAQ:...
Shares of embattled electric-truck start-up Nikola (NASDAQ: NKLA) closed down more than 25% on Wednesday, following reports that energy giant BP (NYSE: BP) has backed away from a potential partnership following allegations that Nikola has misled investors. Nikola's s...
Johnson & Johnson (NYSE: JNJ) has moved into phase 3 development of its coronavirus vaccine candidate, which goes by the code name JNJ-78436735. The study, called Ensemble, will enroll up to 60,000 volunteers across three continents. The company trails Moderna (NASDAQ:...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
52.25%Change Percent:
ASLAN Pharmaceuticals Limited Company Name:
ASLN Stock Symbol:
NASDAQ Market:
aslanpharma.com Website: